Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Extended Longevity
AddedFeb 17, 2024
UpdatedJun 18, 2026
Extended Longevity

Extended Longevity

Seed

Extended Longevity manufactures phytotherapeutic formulations to combat aging effects in humans.

HQ
Kula, HI, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to combat the aging process, Extended Longevity specializes in developing and manufacturing phytotherapeutic formulations. The company's core vision is to help individuals maintain youthfulness and reduce the aging effects on human cells through their unique Synergistic and Mimetic Herbal Analog Phytotherapeutic Extracts. Their products are designed to promote health and vitality, targeting a market focused on longevity and cognitive health.

Extended Longevity has garnered attention for its innovative approach to anti-aging solutions. While specific notable affiliated people and investors are not mentioned, the company's key achievements include the development of proprietary phytotherapeutic protocols and successful clinical studies validating their efficacy. Overall, Extended Longevity has made a significant impact in the biotechnology sector by offering natural, plant-based alternatives to traditional anti-aging treatments.

Extended Longevity - Similar Companies

Longevica logo

Longevica

longevica.com

Longevity Biotech logo

Longevity Biotech

Humanity logo

Humanity

humanity.email

Novos logo

Novos

novoslabs.com

Regenerative Bio logo

Regenerative Bio

regen-bio.us

Longevo logo

Longevo

longevo.com

Juvenescence logo

Juvenescence

juvlabs.com

BioAge Labs logo

BioAge Labs

bioagelabs.com

Rejuveron Life Sciences logo

Rejuveron Life Sciences

rejuveron.com

Rezilient Health logo

Rezilient Health

AgeX Therapeutics logo

AgeX Therapeutics

Zero Longevity Science logo

Zero Longevity Science

zerolongevity.com

Vivo logo

Vivo

teamvivo.com

Phytomedics logo

Phytomedics

OndeCare logo

OndeCare

ondecare.com

Extended Longevity - Quick Facts

Who are Extended Longevity's competitors?

Companies similar to Extended Longevity include Longevica, Longevity Biotech, Humanity and Novos.

When was Extended Longevity founded?

Extended Longevity was founded in 2019.

Where is Extended Longevity's headquarters located?

Extended Longevity's headquarters is located in Kula, HI, US.

When was Extended Longevity's last funding round?

Extended Longevity's most recent funding round was for $100k (USD) in November 2022.

How much has Extended Longevity raised to-date?

As of Nov 30, 2022, Extended Longevity has raised a total of $100k (USD).

How many employees does Extended Longevity have?

Extended Longevity has 5 employees as of Feb 5, 2024.

Extended Longevity - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Transactional
Customer
  • Consumers
Main Product
  • Phytotherapeutics
Tags
  • eCommerce
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research